ArticleFrontiers in immunology2025
Drug repurposing of fostamatinib against cancer via potential cytotoxicity and immune checkpoint regulation.
Maoqiong Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it